Digital Health Market Research Reports
-
25 Jul 2024  |  Global  |  Frost Radar
Frost Radar : Clinical-Grade Wearables, 2024
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Clinical-grade wearables are regulatory-approved devices that provide clinically actionable data for monitoring, diagnostic, and therapeutic applications. As demand for continuous remote monitoring of patients increases to mitigate healthcare challenges, such as rising costs and staff shortages, so will the potential for wearable devices to support...
$4,950.00 -
14 May 2024  |  Global  |  Frost Radar
Frost Radar : Multichannel Marketing Hubs, 2024
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
The Frost Radar for the multichannel marketing hub (MMH) industry analyzes providers offering software solutions that help companies streamline and enhance marketing efforts across multiple channels. It plots 12 selected providers based on 10 growth and innovation criteria, comprising quantitative and qualitative factors. The vertical Growth I...
$4,950.00 -
26 Oct 2021  |  Global  |  Customer Research
Hybrid and Multicloud Healthcare IT Transformation
Findings from the 2020 Frost & Sullivan Global Cloud User Survey
Healthcare providers are accelerating digitization strategies due to the COVID-19 pandemic. The most successful providers leverage cloud computing to meet business agility, cost savings, innovation, data storage, security, and privacy goals. Frost & Sullivan conducted the 2020 Global Cloud User Survey between August and September 2020 in North A...
$4,950.00 -
01 Jun 2021  |  North America  |  Frost Radar
Frost Radar™: US Population Health Management Market, 2021
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
After pausing while the US healthcare industry struggled to contain COVID-19, the stringent audit process for value-based care (VBC) is back in full swing for 90% of Medicare reimbursement that is currently attributed to some form of quality or risk-based payment plan. Additionally, CMS has launched new guidance for value-based reimbursement among ...
$4,950.00